Welcome to kongre.net
Speaker
Analytical Assay Development Manager & Head of Quality Control, Expression Therapeutics LLC
Ian Bayles, Analytical Assay Development Manager & Head of Quality Control at Expression Therapeutics LLC, is speaking at 8th CGT Analytical Development Summit 2026 (Boston, United States of America, 1–3 Dec 2026) in the session “When Comparable Does Not Mean Equivalent: Designing Analytical Comparability Studies That Withstand Regulatory Scrutiny in ex vivo Lentiviral Gene Therapy”.
1–3 Dec 2026Boston, United States of America
Vice President, Analytical Development and Quality Control, Sarepta Therapeutics
Chief Technology Officer, GenSight Biologics
Executive Director, Analytical Strategy, Cell Therapy Global Quality, Bristol Myers Squibb
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Ian Bayles, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].